5/2/23 18:15 | 5/1/23 | NERV | Minerva Neurosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Luthringer Remy | MA | DO | CEO | S.m | -105 | 3.84 | 0 | -27 | -13 | 185 | D | | | | | | | | | | | | | | |
12/16/20 20:29 | 12/14/20 | NERV | Minerva Neurosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Luthringer Remy | MA | DO | CEO | M.d | 0 | 0.00 | 0 | 19 | 2 | 993 | D | | | | | | | | | | | | | | |
12/16/20 20:29 | 12/16/20 | NERV | Minerva Neurosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Luthringer Remy | MA | DO | CEO | S.d | -3 | 2.64 | 0 | -1 | 0 | 993 | D | | | | | | | | | | | | | | |
12/17/19 16:46 | 12/14/19 | NERV | Minerva Neurosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Luthringer Remy | MA | DO | CEO | M.d | 0 | 0.00 | 0 | 19 | 2 | 976 | D | | | | | | | | | | | | | | |
12/17/19 16:46 | 12/17/19 | NERV | Minerva Neurosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Luthringer Remy | MA | DO | CEO | S.d | -17 | 7.10 | 0 | -2 | 0 | 976 | D | | | | | | | | | | | | | | |
12/18/18 16:28 | 12/14/18 | NERV | Minerva Neurosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Luthringer Remy | MA | DO | CEO | M.d | 0 | 0.00 | 0 | 19 | 2 | 959 | D | | | | | | | | | | | | | | |
12/18/18 16:28 | 12/17/18 | NERV | Minerva Neurosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Luthringer Remy | MA | DO | CEO | S.d | -19 | 7.46 | 0 | -3 | 0 | 959 | D | | | | | | | | | | | | | | |
12/15/17 16:44 | 12/14/17 | NERV | Minerva Neurosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Luthringer Remy | MA | DO | CEO | M.d | 0 | 0.00 | 0 | 19 | 2 | 943 | D | | | | | | | | | | | | | | |
12/15/17 16:44 | 12/14/17 | NERV | Minerva Neurosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Luthringer Remy | MA | DO | CEO | S.d | -13 | 5.85 | 0 | -2 | 0 | 943 | D | | | | | | | | | | | | | | |
2/7/17 16:31 | 2/3/17 | NERV | Minerva Neurosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Luthringer Remy | MA | DO | P,CEO | M.dm | 161 | 4.71 | 1 | 34 | 4 | 927 | D | 126 | 105 | -6 | 16 | -12 | 0 | 6 | 4 | -2 | 1 | -14 | -31 | | |
2/7/17 16:31 | 2/3/17 | NERV | Minerva Neurosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Luthringer Remy | MA | DO | P,CEO | S.dm | -378 | 11.02 | 1 | -34 | -4 | 927 | D | 126 | 105 | -6 | 16 | -12 | 0 | 6 | 4 | -2 | 1 | -14 | -31 | | |